Patrick B Donnelly
Stock Analyst at Citi
(3.47)
# 2,224
Out of 4,417 analysts
562
Total ratings
49.2%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintained: Hold | $120 → $140 | $143.39 | -2.36% | 19 | May 29, 2026 | |
| TECH Bio-Techne | Maintained: Buy | $70 | $55.00 | +27.27% | 22 | May 28, 2026 | |
| NTRA Natera | Maintained: Buy | $300 | $226.44 | +32.49% | 4 | May 28, 2026 | |
| SHC Sotera Health Company | Maintained: Buy | $23 | $15.46 | +48.77% | 13 | May 28, 2026 | |
| DHR Danaher | Initiated Coverage: Buy | $265 → $230 | $177.76 | +29.39% | 30 | May 27, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | n/a | $15.32 | - | 13 | May 26, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | $1,550 | $1,129.53 | +37.23% | 18 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $35 → $28 | $17.86 | +56.77% | 5 | May 8, 2026 | |
| BRKR Bruker | Maintained: Hold | $40 → $44 | $54.73 | -19.61% | 29 | May 7, 2026 | |
| QDEL QuidelOrtho | Rated: Hold | $30 → $13 | $13.13 | -0.99% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $55 | $36.42 | +51.02% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $41 → $95 | $159.09 | -40.29% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $9 | $9.46 | -4.86% | 23 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $38 | $36.58 | +3.88% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $375 → $400 | $323.59 | +23.61% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $284.67 | +5.39% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $357.00 | +19.05% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $170.67 | +17.19% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $129.11 | +16.18% | 21 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $24 | $32.13 | -25.30% | 26 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $17.06 | +52.40% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $685 | $461.69 | +48.37% | 31 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 | $124.33 | +48.80% | 37 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $215 | $197.76 | +8.72% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 | $182.34 | +45.33% | 23 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 | $259.56 | +25.21% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $97.82 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $6 | $4.47 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $4.25 | $1.87 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $32.48 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $9.75 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 → $36 | $16.78 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $4.38 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 | $0.0004 | n/a | 1 | Nov 30, 2018 |
ICON Public Limited Company
May 29, 2026
Maintained: Hold
Price Target: $120 → $140
Current: $143.39
Upside: -2.36%
Bio-Techne
May 28, 2026
Maintained: Buy
Price Target: $70
Current: $55.00
Upside: +27.27%
Natera
May 28, 2026
Maintained: Buy
Price Target: $300
Current: $226.44
Upside: +32.49%
Sotera Health Company
May 28, 2026
Maintained: Buy
Price Target: $23
Current: $15.46
Upside: +48.77%
Danaher
May 27, 2026
Initiated Coverage: Buy
Price Target: $265 → $230
Current: $177.76
Upside: +29.39%
Fortrea Holdings
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.32
Upside: -
Mettler-Toledo International
May 8, 2026
Maintained: Buy
Price Target: $1,550
Current: $1,129.53
Upside: +37.23%
Caris Life Sciences
May 8, 2026
Maintained: Buy
Price Target: $35 → $28
Current: $17.86
Upside: +56.77%
Bruker
May 7, 2026
Maintained: Hold
Price Target: $40 → $44
Current: $54.73
Upside: -19.61%
QuidelOrtho
May 6, 2026
Rated: Hold
Price Target: $30 → $13
Current: $13.13
Upside: -0.99%
May 6, 2026
Maintained: Buy
Price Target: $60 → $55
Current: $36.42
Upside: +51.02%
May 4, 2026
Rated: Sell
Price Target: $41 → $95
Current: $159.09
Upside: -40.29%
Apr 30, 2026
Maintained: Hold
Price Target: $11 → $9
Current: $9.46
Upside: -4.86%
Apr 29, 2026
Maintained: Hold
Price Target: $55 → $38
Current: $36.58
Upside: +3.88%
Apr 24, 2026
Maintained: Buy
Price Target: $375 → $400
Current: $323.59
Upside: +23.61%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $284.67
Upside: +5.39%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $357.00
Upside: +19.05%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $170.67
Upside: +17.19%
Apr 7, 2026
Maintained: Buy
Price Target: $150
Current: $129.11
Upside: +16.18%
Apr 7, 2026
Rated: Hold
Price Target: $18 → $24
Current: $32.13
Upside: -25.30%
Apr 7, 2026
Maintained: Buy
Price Target: $26
Current: $17.06
Upside: +52.40%
Apr 6, 2026
Maintained: Buy
Price Target: $685
Current: $461.69
Upside: +48.37%
Mar 11, 2026
Maintained: Buy
Price Target: $185
Current: $124.33
Upside: +48.80%
Feb 11, 2026
Maintained: Hold
Price Target: $215
Current: $197.76
Upside: +8.72%
Jan 15, 2026
Maintained: Buy
Price Target: $265
Current: $182.34
Upside: +45.33%
Jan 2, 2026
Maintained: Buy
Price Target: $325
Current: $259.56
Upside: +25.21%
May 22, 2025
Maintained: Buy
Price Target: $135
Current: $97.82
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $9 → $6
Current: $4.47
Upside: n/a
Mar 23, 2023
Maintained: Hold
Price Target: $1.5 → $4.25
Current: $1.87
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $62
Current: $32.48
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $6
Current: $9.75
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $32 → $36
Current: $16.78
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $4.38
Upside: n/a
Nov 30, 2018
Maintained: Hold
Price Target: $4.5
Current: $0.0004
Upside: n/a